Streetbeat News

Stock Prices

IRON

Disc Medicine shares dropped following the announcement of topline results from the Phase 2 AURORA study of bitopertin in patients with EPP.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:07 pm

BUSE

First Busey Corporation (BUSE) has completed its acquisition of Merchants and Manufacturers Bank Corporation (M&M), effective April 1, 2024. The deal includes a mix of cash and stock, totaling approximately $12.2 million in cash and 1,429,324 shares of Busey common stock. Busey will operate M&M Bank as a separate entity until a merger in June 2024, which will expand Busey's footprint to 62 full-service locations across several states. The acquisition enhances Busey's deposit, commercial banking, and wealth management presence, particularly in the Chicago-Naperville-Elgin, IL-IN-WI Metropolitan Statistical Area, improving its deposit share ranking significantly. Both companies emphasize their commitment to community banking and customer service excellence.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:07 pm

MVLA

Movella Holdings Inc. (NASDAQ:MVLA) announced its voluntary delisting from the Nasdaq Stock Market, with trading suspension expected on April 2, 2024. The company plans to have its securities quoted on an OTC market operated by OTC Markets Group Inc. around or after April 12th, although there's no guarantee of continued trading.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:06 pm

VISL

Vislink Technologies shares are trading higher following the announcement of their Q4 results.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:06 pm

BRK-B

IEO

IJR

On CNBC's 'Halftime Report Final Trades,' experts recommended Berkshire Hathaway Inc. (BRK-B, BRK-A), iShares Core S&P Small-Cap ETF (IJR), and iShares U.S. Oil & Gas Exploration & Production ETF (IEO) based on various financial analyses and market conditions. UBS analyst Brian Meredith maintained a Buy rating on Berkshire Hathaway, raising the price target. The recommendations come amidst a backdrop of increasing crude oil inventories and a rise in WTI crude oil prices.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 1:05 pm

JBHT

Barclays analyst Brandon Oglenski downgraded JB Hunt Transport Services (JBHT) from Overweight to Equal-Weight and reduced the price target from $215 to $200.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:03 pm

WAL

Recent analysis of Western Alliance (NYSE:WAL) by 6 financial analysts shows a mix of bullish to bearish sentiments, with an upward trend in the 12-month price targets, now averaging $81.33. The company, a Las Vegas-based bank holding company, faces challenges in revenue growth and debt management but excels in net margin, ROE, and ROA. Analysts maintain or raise their ratings, reflecting their reaction to the company's performance and market conditions.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 1:01 pm

LLY

Eli Lilly and Co (NYSE:LLY) has received mixed analyst ratings over the past three months, with a notable shift towards more bullish sentiments in recent evaluations. The average 12-month price target for LLY has been raised to $799.0, indicating a 12.89% increase from the previous target. Analysts from firms including Cantor Fitzgerald, Truist Securities, JP Morgan, and others have maintained or raised their ratings, with price targets ranging up to $1000.00. Eli Lilly's financial performance has been strong, with significant revenue growth, high net margin, and exceptional ROE and ROA, although its debt-to-equity ratio indicates a higher level of debt.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 1:00 pm

MRK

Analysts have recently updated their ratings and price targets for Merck & Co (NYSE:MRK), showing a diverse range of opinions but generally positive sentiment. The average 12-month price target has been raised to $134.88, indicating a 3.66% increase from the previous target. The company's financial performance shows a positive revenue trend with a growth rate of 5.78% as of December 31, 2023, but it faces challenges in net margin, ROE, and ROA, which are below industry averages. Merck's strong market presence and substantial size are highlighted by its market capitalization and sound financial structure, as evidenced by a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

April 01, 2024 | 1:00 pm

CNM

CVX

KLAC

LDOS

PFE

SFL

Jim Cramer discussed several companies on CNBC's 'Mad Money Lightning Round,' highlighting their recent performances and analyst ratings. Core & Main reported upbeat sales but missed earnings estimates slightly. KLA Corporation received a Buy rating from Stifel. Chevron is performing well with a 4% yield and a new MOU for CCS development. Pfizer, after acquiring Seagen, was downgraded by Argus Research. Leidos Holdings received a price target increase from B of A Securities. SFL Corporation posted better-than-expected results, but Cramer warned about overstaying in the stock.

Portfolio Pulse from Avi Kapoor

April 01, 2024 | 1:00 pm